Drug maker tracks babies born to mothers on liver medication
NCT ID NCT06258902
Summary
This study aims to understand the safety of the drug odevixibat for pregnant and breastfeeding individuals and their babies. It will collect information from medical records of about 20 people who took the drug during pregnancy or while nursing. The study is purely observational, meaning no extra tests or visits are required—researchers are just gathering data that's already part of normal care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY RELATED are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Virtual Research Coordination Center Odevixibat (BYLVAY) Pregnancy Surveillance Program
RECRUITINGWilmington, North Carolina, 28401, United States
Conditions
Explore the condition pages connected to this study.